Sheaff Brock Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.65M | Sell |
27,067
-2,048
| -7% | -$119K | 0.15% | 119 |
|
|
2024
Q4 | $1.65M | Sell |
29,115
-15,431
| -35% | -$862K | 0.14% | 123 |
|
|
2024
Q3 | $2.3M | Buy |
44,546
+11,387
| +34% | +$534K | 0.2% | 97 |
|
|
2024
Q2 | $1.38M | Sell |
33,159
-795
| -2% | -$35.6K | 0.13% | 133 |
|
|
2024
Q1 | $1.84M | Buy |
33,954
+808
| +2% | +$41.2K | 0.12% | 124 |
|
|
2023
Q4 | $1.7M | Sell |
33,146
-1,612
| -5% | -$84.6K | 0.13% | 117 |
|
|
2023
Q3 | $2.02M | Sell |
34,758
-2,329
| -6% | -$143K | 0.18% | 99 |
|
|
2023
Q2 | $2.37M | Sell |
37,087
-2,756
| -7% | -$185K | 0.2% | 93 |
|
|
2023
Q1 | $2.76M | Sell |
39,843
-1,307
| -3% | -$92.2K | 0.25% | 80 |
|
|
2022
Q4 | $2.96M | Sell |
41,150
-357
| -0.9% | -$26.9K | 0.29% | 70 |
|
|
2022
Q3 | $2.95M | Buy |
41,507
+792
| +2% | +$57.5K | 0.32% | 70 |
|
|
2022
Q2 | $3.13M | Sell |
40,715
-3,575
| -8% | -$272K | 0.26% | 68 |
|
|
2022
Q1 | $3.23M | Sell |
44,290
-12,526
| -22% | -$841K | 0.23% | 75 |
|
|
2021
Q4 | $3.54M | Sell |
56,816
-1,192
| -2% | -$69.9K | 0.24% | 73 |
|
|
2021
Q3 | $3.43M | Sell |
58,008
-72,417
| -56% | -$4.77M | 0.25% | 70 |
|
|
2021
Q2 | $8.71M | Sell |
130,425
-266
| -0.2% | -$17.3K | 0.63% | 22 |
|
|
2021
Q1 | $8.25M | Sell |
130,691
-301
| -0.2% | -$18.7K | 0.65% | 24 |
|
|
2020
Q4 | $8.13M | Buy |
130,992
+11,591
| +10% | +$713K | 0.68% | 21 |
|
|
2020
Q3 | $7.2M | Sell |
119,401
-38,040
| -24% | -$2.29M | 0.66% | 20 |
|
|
2020
Q2 | $9.26M | Sell |
157,441
-53
| -0% | -$3.17K | 0.92% | 11 |
|
|
2020
Q1 | $8.78M | Sell |
157,494
-15,891
| -9% | -$971K | 1.16% | 9 |
|
|
2019
Q4 | $11.1M | Buy |
173,385
+144,781
| +506% | +$8.29M | 1.08% | 10 |
|
|
2019
Q3 | $1.45M | Sell |
28,604
-304
| -1% | -$14.3K | 0.16% | 96 |
|
|
2019
Q2 | $1.31M | Sell |
28,908
-99,986
| -78% | -$4.66M | 0.14% | 104 |
|
|
2019
Q1 | $6.15M | Buy |
128,894
+1,700
| +1% | +$84.7K | 0.75% | 29 |
|
|
2018
Q4 | $6.61M | Sell |
127,194
-1,229
| -1% | -$66K | 1.04% | 20 |
|
|
2018
Q3 | $7.97M | Sell |
128,423
-1,181
| -0.9% | -$70.1K | 0.75% | 20 |
|
|
2018
Q2 | $7.17M | Sell |
129,604
-1,967
| -1% | -$106K | 0.7% | 27 |
|
|
2018
Q1 | $8.32M | Buy |
131,571
+2,449
| +2% | +$158K | 0.86% | 19 |
|
|
2017
Q4 | $7.91M | Sell |
129,122
-24,730
| -16% | -$1.55M | 1.03% | 20 |
|
|
2017
Q3 | $9.81M | Buy |
153,852
+92,715
| +152% | +$5.41M | 1.29% | 12 |
|
|
2017
Q2 | $3.41M | Sell |
61,137
-3,862
| -6% | -$210K | 0.45% | 53 |
|
|
2017
Q1 | $3.54M | Buy |
64,999
+910
| +1% | +$49.9K | 0.46% | 50 |
|
|
2016
Q4 | $3.75M | Sell |
64,089
-5,182
| -7% | -$283K | 0.47% | 50 |
|
|
2016
Q3 | $3.73M | Buy |
69,271
+10,901
| +19% | +$700K | 0.5% | 47 |
|
|
2016
Q2 | $4.29M | Sell |
58,370
-200
| -0.3% | -$14.1K | 0.54% | 45 |
|
|
2016
Q1 | $3.74M | Sell |
58,570
-162
| -0.3% | -$10.2K | 0.46% | 45 |
|
|
2015
Q4 | $4.04M | Buy |
+58,732
| New | +$3.88M | 0.46% | 47 |
|
Other funds holding BMY
Sheaff Brock Investment Advisors's BMY Position: Q1 2025 in Review
Sheaff Brock Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 7% in Q1 2025, selling an estimated $119K and leaving 27,067 shares worth $1.65M. The position accounts for 0.15% of the portfolio, ranked #119.
Sheaff Brock Investment Advisors first reported a position in BMY in Q4 2015 and has held it in 38 quarters since. The position peaked at $11.1M in Q4 2019. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Sheaff Brock Investment Advisors held 27,067 shares of Bristol-Myers Squibb worth $1.65M as of Q1 2025.
- Sheaff Brock Investment Advisors sold 2,048 Bristol-Myers Squibb shares in Q1 2025, an estimated $119K.
- Bristol-Myers Squibb made up 0.15% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #119 holding.
- Sheaff Brock Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 38 quarters since.
- Sheaff Brock Investment Advisors's Bristol-Myers Squibb position peaked at $11.1M in Q4 2019.
- 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.